16.701.94% ( -0.33 )
Delay Trading: Nov 16, 10:50:00Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Staidson BioPharm(300204) the Revenue is 54.29 M (-1.19%);the EBIT is -11 M (-107.2%);the EPS is -0.0307 (-178.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.05B1.19%
----
----
EBIT
-0.01B107.21%
----
----
EPS
-0.0307178.24%
----
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateMar 26, 2027
Estimate Revenue471.15 M
Estimate EBIT13.75 M
Estimate EPS0.03
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly
